✦ LIBER ✦

Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma

✍ Scribed by J. M. Hernández; R. García-Sanz; E. Golvano; J. Bladé; J. Fernandez-Calvo; J. Trujillo; J. A. Soler; S. Gardella; F. Carbonell; G. Mateo; J. F. San Miguel

Book ID: 108672868
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 123 KB
Volume: 127
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2004.05186.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of low-dose prednisone and melph

The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma

✍ Cuttner, Janet ;Wasserman, L. R. ;Martz, Georg ;Sonntag, Roland W. ;Kyle, Robert 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

## Abstract A study was designed to evaluate the effectiveness of prednisone therapy in poor‐risk patients with multiple myeloma. Patients were treated with melphalan alone or in combination with prednisone at doses of either 0.6 mg/kg or 0.3 mg/ kg. The group of patients receiving melphalan and pr

Comparison of melphalan and prednisone w

Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma : Results of Eastern Cooperative Oncology Group study E2479

✍ Martin M. Oken; David P. Harrington; Neil Abramson; Robert A. Kyle; William Knos 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## METHODS. Four hundred seventy-nine previously untreated patients with multiple myeloma from 23 ECOG institutions were enrolled. Treatment, assigned by ran-1 The Virginia Piper Cancer Institute and the Unidomization, consisted of either 4-week cycles of MP or 5-week cycles of VBCMP.

Renal function in the elimination of ora

Renal function in the elimination of oral melphalan in patients with multiple myeloma

✍ C. G. Adair; J. M. Bridges; Z. R. Desai 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 329 KB

Pharmacokinetic studies in 11 patients with multiple myeloma were undertaken on the first and last days of one course of chemotherapy. The drug was administered PO in single doses of 6-14 mg daily. Melphalan concentrations were determined by high-performance liquid chromatography. The interpatient v

A randomised comparison of melphalan wit

A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7

✍ Chaim Shustik; Andrew Belch; Sue Robinson; Sheldon H. Rubin; Sean P. Dolan; Mich 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 760 KB

Effect of thalidomide with melphalan and

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

✍ Silvia G. R. Verelst; F. Termorshuizen; C. A. Uyl-de Groot; M. R. Schaafsma; A. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 274 KB

Cyclophosphamide plus dexamethasone is a

Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma : Results of a randomized comparison with vincristine, doxorubicin, and dexamethasone

✍ Ulf-Henrik Mellqvist; Stig Lenhoff; Hans E. Johnsen; Martin Hjorth; Erik Holmber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract ## BACKGROUND Today, intensive therapy that includes high‐dose melphalan with autologous stem cell transplantation (ASCT) is considered standard therapy in younger patients with newly diagnosed myeloma. When the current trial was initiated, combined vincristine, doxorubicin, and dexame